Parallax Volatility Advisers, L.P. Sangamo Therapeutics, Inc Transaction History

Parallax Volatility Advisers, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $37,220 - $58,328	-3,421 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $11,957 - $18,737	-1,099 Reduced 24.31%	3,421 $43,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $41,719 - $82,173	4,520 New	4,520 $71,000
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $223,661 - $440,537	-24,232 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $153,194 - $203,823	16,332 Added 206.73%	24,232 $229,000
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $69,125 - $102,937	7,900 New	7,900 $85,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $457,155 - $758,569	-59,217 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $985,721 - $1.72 Million	-103,651 Reduced 63.64%	59,217 $680,000
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $2.26 Million - $3.22 Million	162,868 New	162,868 $2.31 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $213,927 - $337,543	-12,810 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $148,596 - $222,253	12,810	12,810 $210,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $135M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.